Drug Development Immersion - last time in Boston this year!
| This week's FierceBiotech is brought to you by Biotech Primer.
Trouble viewing? Click here. |
| Dear E,
Drug Development Immersion is coming to Boston on Nov. 7-8 for the final time in 2019 so you've got one shot left to boost your drug development IQ.
This intensive, two-day course teaches you the regulatory, commercial and scientific considerations required to bring both small molecule and biologic drugs successfully to market so you can hold your own with science colleagues whether you work in finance, law, business development, marketing or just need to understand the drug development process from beginning to end.
You will leave this course with:
Fluency in the terminology and acronyms of drug development An in-depth look at the FDA and EMA regulatory process Understanding of the key issues related to manufacturing a product Familiarity with preclinical testing requirements Appreciation of different aspects of clinical studies and their design 100% of the attendees from the May 2019 course were very satisfied with Drug Development Immersion, found the material relevant to their jobs and would recommend to colleagues.
Here's what some said:
"The instructor was fabulous. I was very impressed with his scope of knowledge."
"There was a thorough explanation of all clinical phases of drug development."
"The instructor had a simple way of explaining complex issues and topics. He tied concepts to real life examples for case studies."
Registration is limited to 28 attendees.
|
|
Biotech Primer is trusted by the largest names in the biopharma industry, with more than 75,000 professionals trained since 2001 at companies such as AbbVie, AstraZeneca, Bristol-Myers Squibb and Genentech.
If you can’t make this course, take a look at our 2019 face-to-face courses for other dates and locations.
Thank you,
Stacey Hawkins
CEO, Biotech Primer
[email protected]
P.S. Contact me if you have multiple employees (15+) who could benefit from this training and we can deliver on-site. |
|
|
|
| Want to reach 137,000+ FierceBiotech subscribers with your own message?
Contact [email protected] or call 202-824-5074.
About this email: In order to receive FierceBiotech for free, we ask that you accept an occasional email promotion from our sponsors. We carefully screen each promotion and never sell or give away your personal information. If you do not want to receive these messages, you can unsubscribe entirely from FierceBiotech.
Click here to unsubscribe. Refer to our Privacy Policy.
FierceMarkets, a division of Questex, LLC
1900 L St. NW Suite 400
Washington, DC 20036 |
|
